ESC 365 - Associate Professor Mateusz Tajstra

Speaker illustration

Associate Professor Mateusz Tajstra

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

Member of:

Presentations Articles

Heart Failure and CRT optimisation with SyncAV™ CRT technology and the role of new development in shaping future device therapies

Event: Heart Failure 2025

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Heart Failure and CRT optimisation with SyncAV™ CRT technology and the role of new development in shaping future device therapies

Safety and feasibility concerns of radiotherapy in the presence of subcutaneous implantable cardioverter-defibrillator

Event: EHRA 2024

Topic: Radiotherapy

Session: Ventricular tachycardia 4

Remote supervision to decrease hospitalization rate study (RESULT) in patients with heart failure and implanted cardioverter-defibrillator or cardiac resynchronization therapy.

Event: EHRA 2019

Topic: Home and Remote Patient Monitoring

Session: Late-breaking trials 2

Hybrid coronary revascularization in selected patients with multivessel disease - 5 year clinical outcomes of the prospective randomized pilot study.

Event: ESC Congress 2018

Topic: Outcome

Session: Outcome of coronary stenting up to 10 years

Comparison of long-term mortality of hybrid coronary revascularization vs. coronary artery bypass grafting. Three-years mortality of Hybrid Revascularization for Multivessel Coronary Artery Disease (H

Event: ESC Congress 2016

Topic: Minimally invasive and robotic surgery

Session: PCI and more

Radiotherapy can cause serious malfunction of modern implantable cardioverters-defibrillators (ICD) and cardiac resynchronization device and defibrillator (CRT-D).

Event: ESC Congress 2016

Topic: Automatic implantable cardioverter / defibrillator

Session: Prevention sudden cardiac death and ICD therapy

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources